Trial Profile
A Phase II clinical study of Goserelin combine with Exemestane in premenopausal women with metastatic breast cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Jan 2014
Price :
$35
*
At a glance
- Drugs Exemestane (Primary) ; Goserelin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 19 Jan 2014 New trial record